ESTER COMPOSITIONS

DE602022018915T2Active Publication Date: 2025-08-06EVONIK OPERATIONS GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602022018915
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-04-07
Filing Date
2022-03-22
Publication Date
2025-08-06
Estimated Expiration
2042-03-22

AI Technical Summary

Technical Problem

Existing cosmetic oils based on petrochemicals have limitations such as high melting points, waxy consistency, and poor applicability, while sustainable alternatives like lauryl olivate and lauryl oleate have disadvantages like wax formation and high enzyme usage, and existing ester synthesis methods produce waxes or require high enzyme charges.

Method used

A mixture composition comprising alkyl carboxylates with specific carbon chain lengths and ratios, prepared using enzyme catalysis, which are liquid at ambient temperature and exhibit excellent properties for cosmetic use, including low polarity, low surface tension, and good spreading behavior.

Benefits of technology

The mixture compositions provide excellent odour, wetting properties, and stability, are suitable for coloured cosmetics, and offer improved skin feel and moisture retention, while being largely derived from renewable resources.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

Field of the invention

[0001] The invention relates to mixture compositions comprising specifically chosen alkyl carboxylates, to a process for the preparation of ester compositions and also to the use of the mixture compositions and ester compositions, particularly in cosmetic applications.Prior art

[0002] Petrochemically-based mineral oils are conventionally often used as inexpensive fillers in oil phases of emulsions. In formulation projects in accordance with the times, though, it is sought as much as possible to avoid a petrochemical source of formulation constituents because of sustainability aspects. For such an application, suitable oils fall in the range of the moderately heavy oils with rather average application properties, such as, e.g., viscosities in the range from 10-50 mPa·s at ambient temperature and surface tensions in the range from 26-32 mN / m and, associated therewith, moderate to good spreading behaviour and moderate to low polarity. A commercially available alternative at least partially consisting of sustainable raw materials is cetyl ethylhexanoate.

[0003] Completely based on sustainable raw materials, for example Sensolene Care DD (INCI: Lauryl Olivate; CAS number: 92113-71-8; EINECS number: 295-679-5) is commercially available for cosmic applications, a yellow wax, soft at 20°C, with a characteristic odour, with 99.0-99.9% active content of lauryl olivate. It is promoted as raw material with protective effect and sensory advantages, such as light and silky feeling on the skin. However, the melting point of the product is in the range from 25-27°C, sometimes even up to a maximum of 32°C, and can be regarded as a crucial disadvantage, since the applicability of a waxy raw material as typical oil for cosmetics, which by definition has to be liquid, is restricted.

[0004] Likewise completely made of sustainable raw materials, Dermol CV (INCI: Lauryl Oleate; CAS number: 36078-10-1) is commercially available for cosmetic applications. It is promoted as weakly occlusive oil which should be suitable for replacing occlusive mineral oils, and also can be used as pigment dispersant.

[0005] Abovementioned lauryl olivate or lauryl oleate can in principle, with the described disadvantages, be used as naturally-based alternatives to conventional petrochemically-based mineral oils.

[0006] The document US 4 826 767 describes the enzymatic reaction of different fatty acids with different fatty alcohols in proportions of fatty acid to fatty alcohol of 1.1:1.0 to 0.9:1.0 with uses of at least 0.45% of lipozymes at 60-80°C and 0.005-1.0 bar for 1-7 h. A disadvantage of the process described in the prior art is that always only pure chain cuts are reacted with each other. An additional disadvantage is the sometimes very high enzyme charge during the reaction. An additional disadvantage is that waxes are obtained as products; a person skilled in the art understands that to mean substances which are solid at 20°C.

[0007] The document US 8 505 736 B1 describes the catalytic synthesis of esters by reaction of linear or branched alcohols with a chain length of C8 to C20 with linear fatty acids with a chain length of C12 to C22 for the preparation of more biodegradable flotation aids for froth flotation. The temperature of the reaction can lie between 100°C and 200°C.

[0008] The document CN101076509A describes the synthesis of esters from fatty alcohols and fatty acids with more than 10 carbon atoms each with the use of a metal hydrate as catalyst.

[0009] JP62104589 describes the reaction of individual alcohols with individual fatty acids in the presence of an organic solvent and alkaline lipase for the preparation of fatty acid esters.

[0010] DE102011006362 A discloses ester mixtures of at least one optionally branched, optionally unsaturated, optionally substituted carboxylic acid having a chain length of 6 to 30, in particular 8 to 22, preferably 10 to 16 carbon atoms with 2-methyl-1-butanol and 3-methyl-1-butanol, the weight ratio of 2-methyl-1-butanol and 3-methyl-1-butanol being from 0.05: 1 to 1:0.05, in particular from 0.1:1 to 1:1, preferably from 0.1:1 to 0.67:1. In Examples 6 and 7, 2-methyl-1-butanol and 3-methyl-1-butanol are reacted together with coconut fatty acid having a combined fatty acid content of chain lengths C12 to C18 of >98% in the presence of Novozyme 435.

[0011] It is an object of the invention to make available oil bodies which exhibit excellent properties for use in cosmetics.Description of the invention

[0012] It has been found that, surprisingly, the mixture compositions and ester compositions described below are able to solve the problem addressed by the invention.

[0013] The present invention therefore provides mixture compositions comprising alkyl carboxylates as described in Claim 1.

[0014] The invention also relates to a process for the preparation of ester compositions as described in Claim 8.

[0015] An advantage of the present invention is that the mixture compositions according to the invention exhibit an excellent odour.

[0016] Another advantage of the present invention is that the mixture compositions according to the invention exhibit excellent wetting properties.

[0017] A further advantage of the present invention is that the mixture compositions according to the invention can be used widely in coloured cosmetics.

[0018] Another advantage of the present invention is that the mixture compositions according to the invention are liquid at ambient temperature and can be used as typical cosmetic oils in emulsions.

[0019] A further advantage of the present invention is that the mixture compositions according to the invention are based on a very high proportion of or even exclusively on renewable raw materials.

[0020] Another advantage of the present invention is that the mixture compositions according to the invention give cosmetic formulations a very good stability, especially with regard to the stability under hot conditions.

[0021] A further advantage of the present invention is that the mixture compositions according to the invention dissolve organic UV screening agents only relatively poorly and accordingly do not contribute to their penetration through the skin barrier.

[0022] Another advantage of the present invention is that the mixture compositions according to the invention give cosmetic formulations a very good feeling on the skin.

[0023] A further advantage of the present invention is that the mixture compositions according to the invention exhibit a particularly good colour.

[0024] Another advantage of the present invention is that the mixture compositions according to the invention exhibit excellent viscosity properties.

[0025] A further advantage of the present invention is that the mixture compositions according to the invention exhibit very low surface tensions.

[0026] Another advantage of the present invention is that the mixture compositions according to the invention exhibit excellent spreading behaviour.

[0027] A further advantage of the present invention is that the mixture compositions according to the invention exhibit very low interfacial tensions.

[0028] A further advantage of the present invention is that the mixture compositions according to the invention exhibit a very low polarity.

[0029] A further advantage of the present invention is that the mixture compositions according to the invention can advantageously be used in applications for skin and hair conditioning and as sensory additive.

[0030] Another advantage of the present invention is that the mixture compositions according to the invention exhibit a protective function and accordingly can advantageously be used to improve skin moisture and to strengthen the skin barrier.

[0031] Another advantage of the present invention is that the mixture compositions according to the invention exhibit a low occlusivity and accordingly, on application to the skin, give this a reduced moisture loss.

[0032] Another advantage of the present invention is that the mixture compositions according to the invention have very ordinary application properties and accordingly can be used very widely in cosmetics, e.g. in coloured cosmetics, deodorants, fragrances, hair products, shaving preparations, depilatories, skin care (body care, eye care, face care, foot care, hand care, lip care, sun care, and the like), soap products and bath products.

[0033] The present invention accordingly relates to a mixture composition comprising a first alkyl carboxylate group of the general formula (Ia) and a second alkyl carboxylate group of the general formula (Ib) with R 1a< and R 1b< chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon acyl radicals exhibiting from 10 to 30, preferably from 10 to 22, particularly preferably from 10 to 18, carbon atoms, R 2a< and R 2b< each chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon radicals exhibiting from 12 to 22, preferably from 12 to 18, particularly preferably from 12 to 14, carbon atoms, with the proviso that R 2a< is different from R 2b< , and that the alkyl carboxylates of the first group and of the second group in total are present in an amount of at least 55% by weight, preferably at least 70% by weight, particularly preferably at least 80% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition, characterized in that the ratio by weight of all alkyl carboxylates of the first group to all alkyl carboxylates of the second group is from 10.0:1.0 to 1.0:1.0, preferably from 4.0:1.0 to 1.5:1.0, particularly preferably from 3.5:1.0 to 2.0:1.0.

[0034] The term "alkyl carboxylates" in connection with the present invention is understood to mean alkyl carboxylates of the general formula (la), in which R 1a< is chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon acyl radicals exhibiting from 1 to 40 carbon atoms and R 2a< is chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon radicals exhibiting from 1 to 40 carbon atoms.

[0035] Unless otherwise indicated, all stated percentages (%) are percentages by weight.

[0036] In the mixture compositions according to the invention, R 1a< and R 1b< can be identical or different, and can also represent mixtures chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon acyl radicals exhibiting from 10 to 30, preferably from 10 to 22, particularly preferably from 10 to 18, carbon atoms.

[0037] In the mixture compositions according to the invention, however, R 2a< and R 2b< are each chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon radicals exhibiting from 12 to 22, preferably from 12 to 18, particularly preferably from 12 to 14, carbon atoms.

[0038] In preferred mixture compositions according to the invention, the alkyl carboxylates of the first group and of the second group in total are present in an amount of 55% by weight to 99% by weight, preferably 70% by weight to 98% by weight, particularly preferably 80% by weight to 97% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

[0039] In preferred mixture compositions according to the invention, the amount of R 1a< , R 1b< , R 2a< and R 2b< radicals, which exhibit an uneven number of carbon atoms, is in total less than or equal to 40% by weight, preferably less than 20% by weight, more preferably still less than 10% by weight, particularly preferably less than 3.0% by weight, the percentages by weight referring to all R 1a< , R 1b< , R 2a< and R 2b< radicals present in the mixture composition.

[0040] In alternatively preferred mixture compositions according to the invention, the amount of R 1a< , R 1b< , R 2a< and R 2b< radicals, which exhibit an uneven number of carbon atoms, is in total greater than 40% by weight, preferably greater than or equal to 50% by weight, more preferably still greater than 60% by weight, particularly preferably greater than 80% by weight, the percentages by weight referring to all R 1a< , R 1b< , R 2a< and R 2b< radicals present in the mixture composition.

[0041] In this connection, the R 1a< , R 1b< , R 2a< and R 2b< radicals exhibiting an uneven number of carbon atoms are those with 11 carbon atoms.

[0042] In preferred mixture compositions according to the invention, R 2a< and R 2b< are each chosen from saturated, linear, optionally hydroxy-substituted, hydrocarbon radicals exhibiting 12 and 14 carbon atoms.

[0043] Preferred mixture compositions according to the invention are characterized in that R 2a< is a lauryl radical and R 2b< is a myristyl radical.

[0044] In preferred mixture compositions according to the invention, R 1a< and R 1b< are chosen from saturated or unsaturated, linear, hydrocarbon acyl radicals exhibiting 18 carbon atoms, preferably unsaturated, particularly preferably mono- and diunsaturated.

[0045] Particularly preferred mixture compositions according to the invention are characterized in that R 2a< is a lauryl radical, R 2b< is a myristyl radical and R 1a< and R 1b< are chosen from mono- and diunsaturated, linear, hydrocarbon acyl radicals exhibiting 18 carbon atoms.

[0046] In this connection, it is preferred according to the invention for the alkyl carboxylates of the first group and of the second group to be present in total in an amount of 70% by weight to 99% by weight, preferably 85% by weight to 95% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

[0047] In this connection, it is furthermore particularly preferred according to the invention for the alkyl carboxylates of the second group to be present in an amount of 15% by weight to 35% by weight, preferably 20% by weight to 30% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

[0048] In this connection, it is furthermore particularly preferred according to the invention for the mixture composition according to the invention to contain lauryl palmitate and / or myristyl myristate in total in an amount of 0.5% by weight to 7.0% by weight, particularly of 1.0% by weight to 5.0% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

[0049] Particularly preferred mixture compositions according to the invention are characterized in that they exhibit a melting point of less than 25°C, preferably of less than 23°C.

[0050] Preferred mixture compositions according to the invention are characterized in that they contain an antioxidant.

[0051] Preferred antioxidants, which according to the invention are preferably present in the mixture composition according to the invention, are chosen from the group containing, preferably consisting of, 3,5-di-tert-butyl-4-hydroxytoluene (BHT), 2-tert-butyl-4-hydroxyanisole and 3-tert-butyl-4-hydroxyanisole, tert-butylhydroquinone (TBHQ), digalloyl trioleate, propyl gallate, octyl gallate, dodecyl gallate, mercaptoacetic acid, sodium thioglycolate, rosmarinic acid, carnosic acid, chlorogenic acid, isoascorbic acid, dexpanthenol, siderophores including catechols, hydroxamates, such as, for example, deferoxamines B, D1, D2, E and H, citrates, cysteine and its derivatives, such as, for example, cysteine hydrochloride and acetylcysteine, ascorbic acid and its derivatives (e.g. ascorbyl glucoside, ascorbyl palmitate, ascorbyl dipalmitate, ascorbyl tetraisopalmitate, magnesium ascorbate, magnesium ascorbyl phosphate), vitamin E (a-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol and α-tocotrienol, β-tocotrienol, γ-tocotrienol and δ-tocotrienol) and its derivatives (e.g. vitamin E acetate, vitamin E linoleate, vitamin E nicotinate, vitamin E succinate), hesperetin, naringenin, flavonoids, taxifolin, catechin, epicatechin, resveratrol and its derivatives (in particular its oligomers), carotenoids (e.g. lycopene, β-carotene, lutein), isosakuranetin, quercetin, eriodictyol, aromadendrin, acacetin, luteolin, kaempferol, apigenin, diosmetin, chrysoeriol, chrysin, galangin, limocitrin, phytic acid and its derivatives, in particular its salts.

[0052] Preferably mixtures of the abovementioned antioxidants can also be used. Particularly preferred are phytic acid and its derivatives, in particular its salts, and also vitamin E (for example in the form of α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, α-tocotrienol, β-tocotrienol, γ-tocotrienol and / or δ-tocotrienol) and its derivatives, in particular as vitamin E acetate, vitamin E linoleate, vitamin E nicotinate or vitamin E succinate, and also their mixtures.

[0053] In preferred mixture compositions according to the invention, the antioxidants are preferably present in an amount of from 0.001% by weight to 5.0% by weight, preferably from 0.01% by weight to 1.0% by weight, particularly from 0.02% by weight to 0.35% by weight, the percentages by weight referring to the total composition.

[0054] The mixture compositions according to the invention can be prepared by all processes known to a person skilled in the art for the preparation of esterification products.

[0055] The present invention further relates to a process, preferably for the preparation of the mixture compositions according to the invention, comprising the process stages A) supplying a first alcohol and a second alcohol, different from the first alcohol, chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon alcohols exhibiting from 12 to 22, preferably from 12 to 18, particularly preferably from 12 to 14, carbon atoms, B) supplying at least one acid chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, carboxylic acids exhibiting from 10 to 30, preferably from 10 to 22, particularly preferably from 10 to 18, carbon atoms, C) esterifying the first and second alcohols with the acid, with an ester composition being obtained, and optionally D) purifying the ester composition, characterized in that the ratio by weight of the amount of the first alcohol to the amount of the second alcohol is from 85.0:15.0 to 1.0:1.0, preferably from 80.0:20.0 to 65.0:35.0, characterized in that the sum of the amount of the first alcohol and of the amount of the second alcohol comes to at least 55% by weight, preferably at least 70% by weight, particularly preferably at least 80% by weight, with reference to all alcohols used in the process.

[0056] A preferred process according to the invention is characterized in that the first alcohol is chosen from lauryl alcohol and the second alcohol is chosen from myristyl alcohol.

[0057] A preferred process according to the invention is characterized in that the acid is chosen from oleic acid and linoleic acid.

[0058] It is preferred according to the invention for process stage C) of the process according to the invention to be carried out by enzyme catalysis.

[0059] The present invention further relates to an ester composition obtainable by the process according to the invention.

[0060] The present invention further relates to the use of a mixture composition according to the invention and / or of an ester composition according to the invention for the preparation of a cosmetic formulation, in particular of a cosmetic sunscreen formulation.

[0061] The present invention further relates to the use of a mixture composition according to the invention and / or of an ester composition according to the invention for the dispersing of solid pigments, in particular of hydrophobized solid pigments.

[0062] The present invention further relates to the use of a mixture composition according to the invention and / or of an ester composition according to the invention for the dissolution of organic UV screening agents.

[0063] In the uses according to the invention, the mixture compositions according to the invention and / or ester compositions according to the invention are, according to their preference, preferably used analogously according to the invention.

[0064] The present invention is described by way of example in the examples cited below, without the invention, the scope of application of which results from the entirety of the description and from the claims, being restricted to the embodiments mentioned in the examples.

[0065] The following figures are an integral part of the examples: Figure 1 shows the phase separation of the emulsions after storage at ambient temperature for two months. Figure 2 shows sensory assessment with regard to oiliness and absorption. Figure 3 shows sensory assessment with regard to oiliness, absorption and tackiness. Figure 4 shows sensory assessment with regard to oiliness, absorption and tackiness after 5 minutes. Examples:Method for determining the acid number

[0066] Suitable methods of determining the acid number are especially those according to DGF C-V 2, DIN EN ISO 2114, Ph. Eur. 2.5.1, ISO 3682 and ASTM D 974.Method for determining the specific activity of the enzyme used in PLU:

[0067] In order to determine the enzyme activity in PLU (propyl laurate units), 1-propanol and lauric acid are mixed homogeneously in an equimolar ratio at 60°C. The reaction is started with addition of enzyme and the reaction is timed. Samples are taken from the reaction mixture at intervals and the content of converted lauric acid is determined by means of titration with potassium hydroxide solution. The enzyme activity in PLU results from the rate at which 1 g of the enzyme in question synthesizes 1 µmol of propyl laurate per minute at 60°C; cf. in this respect also US20070087418, in particular

[0185] .Methods for determining the Hazen colour number

[0068] Suitable methods for determining the Hazen colour number are in particular those according to DIN-ISO 627, DIN EN 1557, ASTM D 1209-84 and DGK F 040.Method for determining the chain distributions of alkyl carboxylates via GC-FID and GC-MS:

[0069] 10 mg of a sample of the corresponding alkyl carboxylate mixture are first dissolved in 1.5 ml of trichloromethane and subsequently 0.15 ml of N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) is added. The derivatization is carried out at 80°C for 30 min. A sample of the clear solution thus obtained is analysed by means of GC-FID and GC-MS. The parameters of the measurement method are: Gas chromatograph: Agilent 7890 Column: Agilent HP-5 (50 m, 0.32 mm, 0.5 µm), Flow rate: constant 2 ml / min with hydrogen (GC-MS: helium) Preliminary heating 80°C, 8°C / min; 300°C, 30 min, injector 1 µl, split 1:20, detector at 310°C Detector: FID, 310°C / GC-MS Scan 35-650 d

[0070] In the GC-FID analysis, the esters present in the sample are separated according to their total chain length. The ratios of the individual esters to each other are determined via the respective area percent of the GC-FID peaks. The identification / assignment of the peaks to the individual ester entities is carried out via GC-MS.

[0071] The chain distributions of the fatty acids and fatty alcohols used as raw materials, their hydroxyl number and their iodine number were taken from the analytical certificates made available.Example ##001#: Preparation of a mixture composition according to the invention

[0072] A mixture of industrial C12 / C14 fatty alcohol (hydroxyl number = 289 mg KOH / g, C12 = 72%, C14 = 26%, 620 g) and oleic acid (acid number = 200 mg KOH / g, iodine number = 93 g I 2 / 100 g, C18:1 78%, 881 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (142950 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.5 mg KOH / g and a Hazen colour number of < 100.Example ##002a#: Preparation of a mixture composition (not according to the invention)

[0073] A bubble column was stocked with a mixture of C8 fatty alcohol (molar mass = 144.21 g / mol, C8 >= 99%, 311 g), C10 fatty alcohol (molar mass = 172.26 g / mol, C10 >= 99.5%, 254 g) and oleic acid (acid number = 202 mg KOH / g, iodine number = 93 g I 2 / 100 g, C18:1 78%, 1000 g) and brought to a temperature of 60°C while continually gassing with nitrogen. After addition of immobilized enzyme Candida antarctica Lipase B (82522 PLU), the mixture was reacted under these conditions for 22 h. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.5 mg KOH / g and a Hazen colour number of < 120.Example ##002b#: Preparation of a mixture composition according to the invention

[0074] A bubble column was stocked with a mixture of industrial C16 / C18 fatty alcohol (hydroxyl number = 216.5 mg KOH / g, C16 = 31%, C18 = 67%, 949 g) and oleic acid (acid number = 202 mg KOH / g, iodine number = 93 g I 2 / 100 g, C18:1 78%, 1000 g) and brought to a temperature of 80°C while continually gassing with nitrogen. After addition of immobilized enzyme Candida antarctica Lipase B (81481 PLU), the mixture was reacted under these conditions for 22 h. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.5 mg KOH / g and a Hazen colour number of < 200.Example ##003#: Preparation of a mixture composition according to the invention

[0075] A mixture of industrial C12 / C14 fatty alcohol (hydroxyl number = 289 mg KOH / g, C12 = 72%, C14 = 26%, 152 g) and oleic acid (acid number = 198 mg KOH / g, iodine number = 91 g I 2 / 100 g, C18:1 ≥ 90%, 220 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (10201 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.6 mg KOH / g and a Hazen colour number of < 50.Example ##004#: Preparation of a product not according to the invention from pure lauryl alcohol and fatty acid mixture

[0076] A mixture of lauryl alcohol (C12 > 99%, 175 g), oleic acid (acid number = 200 mg KOH / g, iodine number = 93 g I 2 / 100 g, C18:1 < 80%, 125 g), palmitic acid (C16 ≥ 99%, 73 g) and stearic acid (C18:0 ≥ 92%, 48 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (21420 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.3 mg KOH / g and a Hazen colour number of < 60.Example ##005#: Preparation of a product not according to the invention from pure lauryl alcohol and pure oleic acid

[0077] A mixture of lauryl alcohol (C12 > 99%, 70.0 g) and oleic acid (acid number = 198 mg KOH / g, iodine number = 91 g I 2 / 100 g, C18:1 >= 89.5%, 96.5 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (8466 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.5 mg KOH / g and a Hazen colour number of < 50.Example ##006#: Preparation of a product not according to the invention from industrial oleic acid with pure lauryl alcohol

[0078] A mixture of lauryl alcohol (C12 > 99%, 120 g) and oleic acid (acid number = 200 mg KOH / g, iodine number = 93 g I 2 / 100 g, C18:1 < 80%, 179 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (15198 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.5 mg KOH / g and a Hazen colour number of < 200.Example ##007#: Preparation of a product not according to the invention from industrial oleic acid and myristyl alcohol

[0079] A mixture of myristyl alcohol (C14 ≥ 96%, 325 g) and oleic acid (acid number = 200 mg KOH / g, iodine number = 93 g I 2 / 100 g, C18:1 < 80%, 419 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (37944 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 0.5 mg KOH / g. Since the product is solid at ambient temperature, the Hazen colour number was determined at 40°C with a value of < 100.Example ##008#: Preparation of a product not according to the invention from pure oleic acid and myristyl alcohol

[0080] A mixture of myristyl alcohol (C14 ≥ 96%, 307 g) and oleic acid (acid number = 198 mg KOH / g, iodine number = 91 g I 2 / 100 g, C18:1 >= 89.5%, 401 g) was heated with stirring to 60°C in a stirred reactor. After addition of immobilized enzyme Candida antarctica Lipase B (36108 PLU), the pressure was lowered to 25 mbar, the mixture was stirred for 24 h and meanwhile the water produced was distilled off continuously. Subsequently, the enzyme was filtered off via a black ribbon filter. The product obtained exhibited an acid number of < 2 mg KOH / g. Since the product is solid at ambient temperature, the Hazen colour number was determined at 40°C with a value of < 50.Application Example ##111#: Storage stability of W / O emulsions

[0081] The alkyl carboxylates according to the invention can be used as typical cosmetic oils in emulsions, in particular if these are to contain a very high proportion of or exclusively naturally-based raw materials. The formulations resulting from this are characterized by a good stability, especially with regard to the stability under hot conditions, and are thereby preferred in comparison with emulsions which use other naturally-based or petrochemically-based oils, which can be regarded as first alternatives. The water-in-oil emulsions shown in Table 1 were prepared. Table 1: Water-in-oil emulsions. Figures in percentage by weight. Conventional preparation of lotions on the 200 g scale. Phase A is heated to 80°C, Phase B (ambient temperature) is added to A using a dropping funnel and stirred at 500 rpm for 2 min with the MIG stirrer, then homogenized at 1300 rpm for 3 min.BR 7 / 20 1 5 2 3 6 7 AIsolan ®< GPS (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate )2.502.502.502.502.502.50Example ##001# (according to the invention) 12.0 0 Example ##003# (according to the Invention) 12.0 0 Example ##005# (not according to the invention) 12.0 0 Example ##006# (not according to the invention) 12.0 0 Example ##007# (not according to the Invention) 12.0 0 Example ##008# (not according to the invention) 12.0 0 Tegosoft ®< DC (Decyl Cocoate)7.007.007.007.007.007.00Prunus Amygdalus Dulcis (Sweet Almond) Oil2.002.002.002.002.002.00Hydrogenated Castor Oil0.300.300.300.300.300.30Cera Alba0.200.200.200.200.200.20dermosoft ®< GMCY (Glyceryl Caprylate)0.500.500.500.500.500.50dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.200.200.200.200.200.20BWaterto 100to 100to 100to 100to 100to 100Glycerin3.003.003.003.003.003.00Zinc Sulfate (Zinc Sulfate Heptahydrate)1.501.501.501.501.501.50

[0082] The viscosities of the formulations are all comparable (10-12 Pa·s; Brookfield viscosity, measured with spindle 5, 10 rpm, at 25°C). All formulations after preparation are viscous and homogeneous. After storage at ambient temperature for two months, a clear phase separation appears for the emulsions containing Examples ##005#, ##006#, ##007# and ##008# not according to the invention, not however with the emulsions containing alkyl carboxylates according to the invention in accordance with Example ##001# and Example ##003#.Application Example ##112#: Pigment dispersion

[0083] Alkyl carboxylates according to the invention can help in the wetting of hydrophobized pigments and accordingly can be widely used in coloured cosmetics. The pigment wetting properties of cosmetic oils can be determined by measuring the viscosity of the pure oil, in comparison with the viscosity of the oil after dispersing a defined amount of pigments. The smaller the increase in viscosity thus determined, the better the property of an oil in wetting pigments on the surface and accordingly in dispersing.

[0084] A standard pigment mixture, as given in Table 2, is investigated. Table 2: Pigment / powder dispersion. Figures in percentage by weight. Conventional preparation of formulations. Phase A is ground until a homogeneous mixture is obtained, then added to Phase B and homogenized at 6000 rpm for 2 min with a Dispermat and a dissolver disc.ST 03 / 20 ATalc (Talcum, Carl Roth)29.43Magnesium Stearate1.04Mica (Cl 77019); Silica (RonaFlair M-Sphere, Merck)4.14Iron Oxides (CI 77491; CI 77492; CI 77499) (Sicovit Brown 70 E 172, BASF)1.25Tego ®< Feel C 10 (Cellulose)4.14BEmollient 60.00

[0085] The viscosities of the oils before addition of the pigment / powder mixture are determined using a Brookfield viscometer, spindle 5, 50 rpm at 20°C. After dispersion of the pigment / powder mixture, the viscosity is again determined in an identical way. The increase in viscosity is represented below: EmollientIncrease in viscosity [mPa·s]Example ##001# (according to the invention) 1240Example ##003# (according to the invention) 1424Example ##006# (not according to the invention) 1904Example ##005# (not according to the invention) 1680Example ##007# (not according to the Invention) max. (crystallization)Example ##008# (not according to the invention) 3936 (crystallization)Dermofeel ®< sensolv (Isoamyl Laurate) 1820Cetyl Ethylhexanoate 2520Mineral Oil 30 mPa·s 4360

[0086] The increase in viscosity of the pigment / powder dispersion in mineral oil is greatest; the dispersibility in this oil is very poor. On using cetyl ethylhexanoate or dermofeel ®< sensolv (Isoamyl Laurate, which is well known for its ability to disperse pigments, compare EP2691157), the increase in viscosity can be clearly reduced; the dispersibility is thus improved; however not yet to the level which is achieved on using Example ##001# and Example ##003# according to the invention. Pigment / powder mixtures with Example ##008# and ##007# not according to the invention show (partial) crystallization and increased or maximum (not measurable with spindle 5, 50 rpm at 20°C) viscosity resulting therefrom.

[0087] Additionally, mixtures of cosmetic oils with pure pigments as given in table 2a were prepared. Here too, the pigment wetting properties of cosmetic oils can be determined by measuring the viscosity of the pure oil, in comparison with the viscosity of the oil after dispersing a defined amount of the pure pigment. The smaller the increase in viscosity thus determined, the better the property of an oil in wetting pigments on the surface and accordingly in dispersing. Table 2a: Mixtures of pure pigments with cosmetic oil. Preparation of mixture with w / w ratio according to the table.PigmentTitanium Dioxide (CI 77891); Dimethicone (DHL-TRI-77891, US Cosmetics)60:40Carbon Black (CI77266, UniPure Black LC 902, Sensient)15:85(Yellow) Iron Oxide (CI 77492); Dimethicone (BYO-DS4, KOBO)40:60(Red) Iron Oxides (CI 77491); Dimethicone (BYO-DS3, KOBO)65:35(Black) Iron Oxides (CI 77499); Dimethicone (BYO-DS3, KOBO)60:40

[0088] The mixture is then stirred for 3 min at 3,500 rpm's and placed onto rheometer for measurement (Anton Paar Modular Compact Rheometer model MCR 302, 20°C, 1 / 100 sec). The viscosities of the neat cosmetics oils are also measured. Pigment mixtures and neat cosmetic oils are run in triplicate and the results averaged.

[0089] The increase in viscosity comparing the neat cosmetic oil and the pigment / cosmetic oil mixture is represented below (given in mPa·s): Titanium Dioxide (CI 77891);Carbon Black (CI77266, UniPure Black LC 902, Sensient)(Yellow) Iron Oxide (CI 77492);(Red) Iron Oxides (CI 77491);(Black) Iron Oxides (CI 77499);Dimethicone (DHL-TRI-77891, US Cosmetics)Dimethicone (BYO-DS4, KOBO)Dimethicon e (BYO-DS3, KOBO)Dimethicone (BYO-DS3, KOBO)Example ##001# (according to the invention) 102104135381133Example ##003# 136124146397148(according to the invention) Example ##006# (not according to the Invention) 180162176460186Example ##007# (not according to the invention) Max (crystallizatio n)860Max (crystallizatio n6420Max (crystallizatio n)Example ##008# (not according to the invention) 1120 (crystallizatio n)868 (crystallizatio n)2604 (crystallizatio n)67308509 (crystallizatio n)Cetyl Ethylhexanoat e 807625235753938718Mineral Oil 30 mPa·s 12309752805796010700Dermofeel ®< sensolv (Isoamyl Laurate) 1212231952238458

[0090] The increase in viscosity of the pigment / cosmetics oil mixture is greatest when using mineral oil; the dispersibility in this oil is very poor. On using cetyl ethylhexanoate or dermofeel ®< sensolv (Isoamyl Laurate), the increase in viscosity can be clearly reduced; the dispersibility is thus improved; however not yet to the level which is achieved on using Example ##001# and Example ##003# according to the invention. Pigment / cosmetics oil mixtures with Example ##008# and ##007# not according to the invention show (partial) crystallization and increased or maximum (not measurable) viscosity resulting therefrom.Application Example ##113#: Sensory evaluating of W / O lotions in comparison with mineral oil

[0091] The formulations shown in Table 3 were prepared. The influence on the feeling on the skin of the formulations was investigated by a test panel. Fourteen trained people each applied a defined amount of approx. 25 µl of the formulations to a defined test field on the inside of the forearm without knowing the composition of the formulations. The formulations were spread in the test field with the help of a finger through circular movements until noticeable absorption was achieved (maximum 60 circles). The parameters of oiliness and absorption were assessed on a scale from 0 to 10 five minutes after application of the sample to the skin. Table 3 Water-in-Oil Emulsions. Figures in percentage by weight. Conventional preparation of lotions on the 200 g scale. Phase A is heated to 80°C, Phase B (ambient temperature) is added to A using a dropping funnel and stirred at 500 rpm for 2 min with the MIG stirrer, then homogenized at 1300 rpm for 3 min.BR 3 / 20 7 8 17 18 AIsolan ®< GPS (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate)2.502.502.502.50Mineral Oil (30 mPa·s) (not according to the invention) 12.00 Example ##001# (according to the invention) 12.00 Example ##005# (not according to the invention) 12.00 Example ##006# (not according to the invention) 12.00 Tegosoft ®< DC MB (Decyl Cocoate)7.007.007.007.00Prunus Amygdalus Dulcis (Sweet Almond) Oil2.002.002.002.00Zinc Stearate0.500.500.500.50Hydrogenated Castor Oil0.300.300.300.30Cera Alba0.200.200.200.20dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.200.200.200.20BWaterto 100to 100to 100to 100Glycerin3.003.003.003.00Zinc Sulfate (Zinc Sulfate Heptahydrate)1.501.501.501.50Panthenol0.500.500.500.50Sorbitol (97% in water)1.501.501.501.50Verstatil ®< TBG MB (Triethyl Citrate; Glyceryl Caprylate; Benzoic Acid)1.001.001.001.00

[0092] Figure 2 shows that the formulation with Example ##001#, in comparison with mineral oil, is appreciably less oily and shows much better absorption. Examples ##005# and ##006# not according to the invention also show improved properties in comparison with mineral oil, however not coming up to the standard of the example according to the invention.Application Example ##114#: Sensory evaluating of O / W lotions in comparison with mineral oil and cetyl ethylhexanoate

[0093] The formulations shown in Table 4 were prepared. The influence on the feeling on the skin of the formulations was investigated by a test panel. Ten trained people each applied a defined amount of approx. 25 µl of the formulations to a defined test field on the inside of the forearm without knowing the composition of the formulations. The formulations were spread in the test field with the help of a finger through circular movements until noticeable absorption was achieved (maximum 60 circles). The parameters of whitening, oiliness, absorption and tackiness were assessed on a scale from 0 to 10 during the spreading of the sample on the skin and also the parameters of oiliness, absorption and tackiness again after five minutes. Table 4 Oil-in-Water Emulsions. Figures in percentage by weight. Conventional preparation of lotions on the 200 g scale. Phase A and B are heated to 70-75°C, Phase B is added to A and homogenized at 20 500 rpm with an UltraTurrax for 90 s, then cooled down to 40°C, Phase C is added and stirred at 13 500 rpm with an UltraTurrax for 30 s. Phase D is then added.BR 2 / 20 8 9 10 Adermofeel ®< NC MB (Polyglyceryl-3 Distearate; Glyceryl Stearate Citrate)2.002.002.00Tego ®< Alkanol 1618 (Cetearyl Alcohol)1.001.001.00Cetyl Ethylhexanoate (not according to the invention) 12.00 Mineral Oil (30 mPa·s) (not according to the invention) 12.00 Example ##002a# (according to the invention) 12.00 dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.200.200.20BWaterto 100to 100to 100Glycerin3.003.003.00CXanthan Gum (Keltrol CG-SFT, CP Kelco)0.200.200.20DVerstatil ®< SL non GMO (Aqua; Sodium Levulinate; Potassium Sorbate)1.501.501.50

[0094] Figure 3 shows that the formulation with Example #002a#, in comparison with cetyl ethylhexanoate and mineral oil, is less whitened and less oily, absorbs faster and is less tacky.

[0095] Figure 4 shows that the formulation with Example #002a#, five minutes after application, in comparison with cetyl ethylhexanoate and mineral oil, is less oily, absorbs more completely and is less tacky.

[0096] These results show that O / W lotions containing oils according to the invention are of higher quality sensorially than O / W lotions containing oils not according to the invention.Application Example ##114a#: Sensory evaluating of makeup foundation in comparison with castor oil

[0097] The formulations shown in table 4a were prepared. The influence on the feeling on the skin of the formulations was investigated by a test panel. Ten trained people each applied a defined amount of approx. 25 µl of the formulations to a defined test field on the inside of the forearm without knowing the composition of the formulations. The formulations were spread in the test field with the help of a finger through circular movements until noticeable absorption was achieved (maximum 60 circles). The parameters of waxiness, oiliness, absorption and tackiness were assessed on a scale from 0 to 10 during the spreading of the sample on the skin and also the parameters of waxiness, oiliness, absorption and tackiness again after five minutes. Table 4a Makeup Foundation. Figures in percentage by weight. Conventional preparation on the 200 g scale. Heat phase A up to 85°C until completely melted. Mix and grind pigments of phase B and add stepwise to phase A while stirring. Add ingredient of phase C. Premix phase D and add to batch. Homogenize. Allow to cool down to 75°C and keep stirring for appr. 15 min. to remove remaining air or use vacuum. Pour into suitable containers at appr. 70°C.PhaseRaw materialC03-4.6-1221 C03-4.7-0122 Adermofeel ®< viscolid MB (Hydrogenated Palm Oil; Hydrogenated Rapeseed Oil)4.004.00Copernicia Cerifera Cera (Kahlwax 2442L, KahlWax)4.504.50Cera Alba (Kahlwax 8104, KahlWax)5.005.00Ricinus Communis (Castor) Seed Oil28.7528.75Hydrogenated Castor Oil3.003.00Example ##001#7.50Ricinus Communis (Castor) Seed Oil7.50Tegosoft ®< DC MB (Decyl Cocoate)22.0022.00dermosoft ®< GMCY MB (Glyceryl Caprylate)0.600.60dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus Seed Oil)0.200.20BCI 77891; Silica (Unipure White LC981 EM, Sensient)15.5015.50CI 77492; Silica (Unipure Yellow LC182 EM, Sensient)1.901.90CI 77491(Unipure Red LC 381 EM, Sensient)0.600.60Cdermosoft ®< Pentiol eco (Pentylene Glycol)0.200.20DSpherilex ®< 10 PC (Hydrated Silica)1.751.75TEGO ®< Feel C 10 (Cellulose)2.002.00 Table X: Sensory Evaluation in comparison with castor oil Waxines sOilines sAbsorptio nTackines sWaxines s (5 min)Oilines s (5 min)Absorptio n (5 min)Tackines s (5 min)C03 -4.6-122 1 5.23.63.04.14.83.14.63.8C03 -4.7-012 2 6.84.02.85.97.13.83.05.5

[0098] Table X shows that the formulation C03-4.6-1221, where parts of castor oil (not according to the invention) have been exchanged with Example ##001# (according to the invention), in comparison to C03-4.7-0122 provides less waxiness, oiliness and tackiness combined with slightly higher absorption. Also, after 5 min on skin, the waxiness, oiliness and tackiness is reduced while also the absorption is now particularly higher.

[0099] These results show that makeup formulation containing oils according to the invention are of higher quality sensorially than makeup formulations containing oils not according to the invention.Application Example ##115#: Dissolution capacity of UV light protection filters

[0100] To test the dissolution capacity of UV light protection filters, the following crystalline UVA or UVB light protection filters were chosen: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (BEMT) Butyl Methoxydibenzoylmethane (BMDM) Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) Ethylhexyl Triazone (EHT)

[0101] To determine the dissolution capacity for the UV light protection filters, a certain amount (50 g) of one of the compounds according to the invention was introduced in each case and brought to a temperature of 22°C. A percentage by weight of a UV light protection filter was added and stirred until this amount had completely and homogeneously dissolved. This operation was repeated until the maximal soluble amount of the UV light protection filter had been exceeded. At higher concentrations, a longer stirring time of several hours is often required for complete dissolution.

[0102] If the maximum concentration had been roughly determined in this manner, the fine determination of the concentration range was achieved by repetition around this maximum concentration using smaller weighed amounts of the UV light protection filter. BEMTBMDMDHHBEHTExample ##001# (according to the invention)3.9%7.9%5.1%1.6%Example ##005# (not according to the invention)4.3%8.0%6.2%2.1%Example ##006# (not according to the invention)4.2%7.9%6.0%1.6%Cetearyl Ethylhexanoate6.2%8.5%5.1%2.2%Ethylhexyl Palmitate7.8%8.1%5.7%4.4%

[0103] In comparison with Example ##005# and Example ##006# as well as also in comparison with other oils normally used in sun protection applications, such as cetearyl ethylhexanoate or ethylhexyl palmitate, Example ##001# according to the invention is characterized by the on the whole lowest UV filter solubilities. This relatively low UV filter solubility is an ideal property of the oils according to the invention in sun protection applications, in which it is used together with other oils which sometimes exhibit very high UV filter solubilities. The high UV filter solubilities are in this connection necessary in order to satisfactorily dissolve the UV filters and to prevent them from crystallizing out. Oils according to the invention behave neutrally in this regard: the UV filter solubilities are not so low that they bring about crystallization of the UV filters but also not so high that they might be in danger of accelerating the penetration of UV filters via the skin barrier.Application Example ##116#: Perception of odour

[0104] Specimens of the samples not according to the invention from Example ##006#, Example ##007# and Example ##008# and of Example ##001# according to the invention are supplied to an odour panel. For this, specimens of the samples are transferred into each time separate sample bottles, which sample bottles are half-filled. These samples are subsequently stored with a closed cover and at ambient temperature for 2 h. The odour test takes place in an odourless place. Four test persons sniff the samples in succession and subsequently give an assessment for each sample individually, with the following classification: (1) good assessment, (2) moderate assessment and (3) poor assessment. The test result results as mean value of the assessments. Example ##006# (not according to the invention)Example ##008# (not according to the invention)Example ##007# (not according to the invention)Example ##001# (according to the invention)Test result of the odour test2.02.01.751.5

[0105] These results show that Example ##001# according to the invention, in comparison with products not according to the invention, leads to a perception of improved odour.Formulation examples:

[0106] The mixture compositions according to the invention can be used in different cosmetic formulations, such as, e.g., oil-in-water emulsions, water-in-oil emulsions or anhydrous systems.

[0107] The formulation examples should serve to illustrate the usability of the mixture compositions in cosmetic emulsions by way of example and do not limit the subject-matter of the invention.

[0108] All quantitative data in % are, unless otherwise stated, parts by weight. Preparation and homogenization stages are carried out according to the usual methods.

[0109] The formulation examples listed below are listed with Example ##001#.

[0110] All formulation examples listed subsequently are additionally each time represented with Example ##002# and ##003# in place of Example ##001# as ingredient.Natural body spray

[0111] PhaseRaw materialw / w %ATego ®< Care LTP (Sorbitan Laurate; Polyglyceryl-4 Laurate; Dilauryl Citrate)2.50Example ##001# 12.50 BWatertoGlycerin3.00Gellan Gum (Kelcogel CG-HA, CP Kelco)0.10Cdermsosoft ®< OMP (Methylpropanediol; Caprylyl Glycol; Phenylpropanol)2.50 W / O Cream

[0112] PhaseRaw materialw / w %AIsolan ®< PDI (Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate)3.00Isolan ®< 17 (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (and) Caprylic / Capric Triglyceride (and) Polyglyceryl-3 Oleate (and) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate)3.00Polyglyceryl-3 Polyricinoleate3.00Hydrogenated Castor Oil0.400.400.40Cera Alba0.600.600.60Tegosoft ®< CT (Caprylic / Capric Triglyceride)5.005.005.00Tegosoft ®< P (Isopropyl Palmitate)5.005.005.00Tegosoft ®< OER (Oleyl Erucate)3.003.003.00Prunus Amygdalus Dulcis (Sweet Almond) Oil3.003.003.00Example ##001# 6.006.006.00BWaterto 100to 100to 100Glycerin5.005.005.00CMagnesium Sulfate Heptahydrate1.001.001.00Sodium Benzoate, Potassium Sorbate, Water (Euxyl K 712, Schülke & Mayr)0.500.500.50Citric Acid (10% in water)q.s.q.s.q.s. Anti-Ageing Day Care

[0113] PhaseRaw materialw / w %Abil ®< EM 90 (Cetyl PEG / PPG-10 / 1 Dimethicone Triglyceride)3.00Tegosoft ®< AC (Isoamyl Cocoate)5.00Tegosoft ®< DEC (Diethylhexyl Carbonate)5.00Abil ®< Wax 9801 (Cetyl Dimethicone)1.50Example ##001# 7.00HyaCare ®< Filler CL (Aqua, Ethylhexyl Stearate, Sodium Hyaluronate Crosspolymer, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate, Sodium Isostearate)2.50Tocopherol0.50Methyl Methacrylate Crosspolymer (Covabead LH 85, Sensient)2.00BWaterto 100Sodium Chloride0.80Glycerin4.00Butylene Glycol4.00Tego ®< Pep 4-Even (Tetrapeptide-30; Glycerin)2.50Sodium Ascorbyl Palmitate1.50Urea2.50Sodium Bisulfite0.10ZPreservative, Perfumeq.s. W / O emulsion

[0114] PhaseRaw materialw / w %AAbil ®< EM 90 (Cetyl PEG / PPG-10 / 1 Dimethicone)2.00Tegosoft ®< OP (Ethylhexyl Palmitate)5.00Tegosoft ®< CT (Caprylic / Capric Triglyceride)5.00Tegosoft ®< DEC (Diethylhexyl Carbonate)10.00Example ##001# 6.00dermofeel ®< viscolid (Hydrogenated Vegetable Oil)0.50BWaterto 100Sodium Chloride0.50CPhenoxyethanol, Ethylhexylglycerin (Euxyl ®< PE 9010, Schülke & Mayr)0.80 Skin serum

[0115] PhaseRaw materialw / w %ATego ®< Care 165 (Glyceryl Stearate; PEG-100 Stearate)3.00Tego ®< Alkanol 18 (Stearyl Alcohol)0.50Isononyl Isononanoate4.00Hydrogenated Polyisobutene3.00Tegosoft ®< APM (PPG-3 Myristyl Ether)3.00Example ##001# 0.50Tocopherol0.50BWaterto 100Butylene Glycol5.00Skinmimics ®< (Ceteareth-25; Glycerin; Cetyl Alcohol; Behenic Acid; Cholesterol; Ceramide NP; Ceramide NS; Ceramide EOS; Ceramide EOP; Ceramide AP; Caprooyl Phytosphingosine; Caprooyl Sphingosine)2.50CPolyacrylamide; C13-14 Isoparaffin; Laureth-7 (Sepigel 305, Seppic)0.75ZPreservative, Perfumeq.s. Body cream

[0116] PhaseRaw materialw / w %ADermofeel NC (Polyglyceryl-3 Distearate; Glyceryl Stearate Citrate)4.00Tego ®< Alkanol 18 (Stearyl Alcohol)1.50Tegosoft ®< CT (Caprylic / Capric Triglyceride)4.50Example ##001# 8.50Tocopherol0.50Varisoft ®< TA 100 (Distearyldimonium Chloride)2.50HyaCare 50 (Hydrolyzed Hyaluronic Acid)0.20BWaterto 100Glycerin7.00Skinmimics ®< (Ceteareth-25; Glycerin; Cetyl Alcohol; Behenic Acid; Cholesterol; Ceramide NP; Ceramide NS; Ceramide EOS; Ceramide EOP; Ceramide AP; Caprooyl Phytosphingosine; Caprooyl Sphingosine)1.50CXanthan Gum0.50ZPreservative, Perfumeq.s. Body butter

[0117] PhaseRaw materialw / w %ADermofeel ®< NC (Polyglyceryl-3 Distearate; Glyceryl Stearate Citrate)3.00Tego ®< Alkanol 1618 (Cetearyl Alcohol)4.00Tegin ®< M Pellets (Glyceryl Stearate)3.00Example ##001# 6.00Helianthus Annuus (Sunflower) Seed Oil5.50Butyrospermum Parkii (Shea) Butter6.00Theobroma Cacao (Cocoa) Seed Butter6.00dermofeel ®< Toco 70 non GMO (Tocopherol; Helianthus Annuus (Sunflower) Seed Oil)0.50BWaterto 100 Glycerin5.00Xanthan Gum (Keltrol CG-SFT, CP Kelco)0.50ZPreservative, Perfumeq.s. Low whitening natural Body butter

[0118] PhaseRaw materialw / w %Asymbio ®< muls GC MB (Glyceryl Stearate Citrate; Cetearyl Alcohol; Glyceryl Caprylate)7.00Helianthus Annuus (Sunflower) Seed Oil35.00Example ##001# 19.00dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.50BWaterTo 100Glycerin3.00dermosoft ®< anisate eco (Sodium Anisate)0.30Cdermofeel ®< PA-3 (Sodium Phytate; Aqua; Alcohol)0.30ZPerfume q.s. Double-Effect Wrinkle Serum

[0119] PhaseRaw materialw / w %AAbil ®< EM 97 S (Bis-PEG / PPG-14 / 14 Dimethicone; Dimethicone)1.00Abil ®< EM 90 (Cetyl PEG / PPG-10 / 1 Dimethicone)1.50Dimethicone (5 mPas)12.009040 Silicone Elastomer Blend (Dow Corning) (Cyclopentasiloxane, Dimethicone Crosspolymer)3.00Tegosoft ®< DEC (Diethylhexyl Carbonate)3.00Example ##001# 0.75HyaCare ®< Filler CL (Aqua; Ethylhexyl Stearate; Sodium Hyaluronate Crosspolymer; Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate; Sodium Isostearate)2.50Tocopherol0.50Zinc Stearate0.50BWaterto 100Sodium Chloride0.80Glycerin4.00Butylene Glycol4.00Tego ®< Pep 4-17 (Tetrapeptide-21; Glycerin; Butylene Glycol; Water)0.50ZPreservative, Perfumeq.s. Lip filler Lipstick

[0120] PhaseRaw materialw / w %ATegosoft ®< G 20 (Octyldodecanol)15.00Tegosoft ®< CT (Caprylic / Capric Triglyceride)10.00Tegosoft ®< OER (Oleyl Erucate)2.00Tegosoft ®< MM (Myristyl Myristate)5.00Ricinus Communis Seed Oil (Castor Oil, Aldrich)31.70Olus Oil (Cremerlin ®< PURA, Cremer Care)10.00Stearyl Beeswax; Behenyl Beeswax (BW Ester BW67, Koster Keunen)5.00Ozokerite (Kahlwax 1899, KahlWax)5.00Cera Alba (Kahlwax 8104, KahlWax)4.00Euphorbia Cerifera Wax (Kahlwax 2039L, KahlWax)2.00Example ##001# 5.00BTocopherol0.10Perfume0.20CHyaCare ®< Filler CL (Aqua; Ethylhexyl Stearate; Sodium Hyaluronate Crosspolymer; Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate; Sodium Isostearate)5.00 W / O emulsion

[0121] PhaseRaw materialw / w %AExample ##001# 4.50Dimethicone; PEG / PPG-18 / 18 Dimethicone10.00Dimethicone;13.00C12-15 Alkyl Benzoate0.50BWaterto 100Glycerin5.00Sodium Chloride2.00CPropylene Glycol; Diazolidinyl Urea; Methylparaben; Propylparaben0.50 O / W Cream

[0122] PhaseRaw materialw / w %w / w %ATego ®< Care PSC 3 (Polyglyceryl-3 Dicitrate / Stearate)3.00C14-22 Alcohols (and) C12-20 Alkyl Glucoside4.00Glyceryl Stearate SE4.50Tegin ®< M Pellets (Glyceryl Stearate)0.900.900.90Tego ®< Alkanol 18 (Stearyl Alcohol)0.600.600.60Tegosoft ®< P (Isopropyl Palmitate)3.003.003.00Prunus Amygdalus Dulcis (Sweet Almond) Oil5.005.005.00Tegosoft ®< CT (Caprylic / Capric Triglyceride)4.504.504.50Triisostearin3.503.503.50Example ##001# 6.006.006.00BWaterto 100to 100to 100Glycerin3.003.003.00Xanthan Gum (Keltrol CG-SFT, CP Kelco)0.300.300.30CSodium hydroxide (10% in water)q.s.q.s.q.s.ZPreservative, Perfumeq.s.q.s.q.s. Natural Refresh Serum

[0123] PhaseRaw materialw / w %dermofeel ®< easymuls plus (Glyceryl Oleate Citrate)2.60Example ##001# 9.30Tegosoft ®< DC (Decyl Cocoate)6.00Xanthan Gum (Xanthan Gum FEDCS-PC, Jungbunzlauer)0.50Magnesium Aluminum Silicate (Veegum Ultra Granules, RT Vanderbilt)1.00WaterTo 100Glycerin5.00Sodium Citrate0.15dermofeel ®< PA-3 (Sodium Phytate; Aqua; Alcohol)0.10Verstatil ®< TBG MB (Triethyl Citrate; Glyceryl Caprylate; Benzoic Acid1.50Perfume q.s.Sodium hydroxide (10% in water)q.s. Lip Filler Coloured lipstick

[0124] PhaseRaw materialw / w %ARicinus Communis Seed Oil; (Castor Oil, Aldrich)21.70Example ##001# 20.00Triisostearin10.00Tegosoft ®< OER (Oleyl Erucate)5.00Tegosoft ®< MM (Myristyl Myristate)7.50Euphorbia Cerifera Wax (Kahlwax 2039L, KahlWax)6.00Copernicia Cerifera Cera (Kahlwax 2442L, KahlWax)3.00Ozokerite (Kahlwax 1899, KahlWax)4.00Polyglyceryl-3 Beeswax (Cera Bellina, Koster Keunen)4.00CI 15850 (Red No. 7), Hydrogenated Polydecene, Hydroxystearic Acid (Creasperse Bergonia, The Innovation Company)2.00BMica, CI 77491 (1:1) (Colorona Bordeaux, Merck)8.50Tego ®< Feel C 10 (Cellulose)3.00CPerfume0.30DHyaCare ®< Filler CL (Aqua; Ethylhexyl Stearate; Sodium Hyaluronate Crosspolymer; Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate; Sodium Isostearate)5.00 Natural lipstick

[0125] PhaseRaw materialw / w %ARicinus Communis Seed Oil (Castor Oil, Aldrich)34.70Example ##001# 7.50Dermofeel ®< sensolv (Isoamyl Laurate)4.00Tegosoft ®< CT (Caprylic / Capric Triglyceride)1.00Tegosoft ®< CR (Cetyl Ricinoleate)14.00ISOLAN ®< GPS (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate)2.00Hydrogenated Castor Oil1.00Cera Alba (Kahlwax 8104, KahlWax)5.00Coperniccia Cerifera Cera (Kahlwax 6642, KahlWax)5.00Candelilla Cera (Kahlwax 2039L, KahlWax)5.00AEROSIL ®< 200 (Silica)1.00dermosoft ®< GMC MB (Glyceryl Caprate)1.00dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.50BMaltodextrin; Raphanus Sativus Root Extract; Citric Acid (Natpure Xfine Radish RR311, Sensient)3.00Raphanus Sativus Root Extract; Maltodextrin; Citric Acid (Natpure Xfine Radish RR318, Sensient)6.00CI 77891; Mica; Silica (Timiron Splendid Red, Merck)4.00Mica; Silica (Ronaflair M-Sphere, Merck)2.00ZParfumq.s. Natural Foundation

[0126] PhaseRaw materialw / w %AExample ##001# 15.00Tegosoft ®< DC (Decyl Cocoate)3.00Tegosoft ®< AC (Isoamyl Cocoate)5.00Carthamus Tinctorius (Safflower) Seed Oil500ISOLAN ®< GPS (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate)4.00Hydrogenated Castor Oil7.00AEROSIL ®< 200 (Silica)0.30SPHINGONY ®< (Sphinganine)0.10dermofeel ®< TocoBalance (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.10BWaterTo 100Glycerin5.00TEGO ®< Natural Betaine 1.00Zinc Sulfate1.50CCI 77891, Hydrogenated Lecithin (Unipure White LC 981 HLC, Sensient)5.00CI 77492, Hydrogenated Lecithin (Unipure Yellow LC 182 HLC, Sensient)1.20CI 77491, Hydrogenated Lecithin (Unipure Red LC 381 HLC. Sensient)0.20CI 77499, Hydrogenated Lecithin (Unipure Black LC 989 HLC, Sensient)0.10Titanium Dioxide (Nano), Alumina; Stearic Acid (Eusolex T-S, Merck KgaA)3.00Zinc Oxide (Zano M, EverZinc)6.00dermosoft ®< 250 eco (Phenylpropanol)0.30ZParfumq.s. Compact Cream Foundation

[0127] PhaseRaw materialw / w %Adermofeel ®< viscolid MB (Hydrogenated Palm Oil; Hydrogenated Rapeseed Oil)4.00Copernicia Cerifera Cera (Kahlwax 2442L, KahlWax)4.50Cera Alba (Kahlwax 8104, KahlWax)5.00Ricinus Communis (Castor) Seed Oil28.75Hydrogenated Castor Oil3.00Example ##001# 7.50Tegosoft ®< DC MB (Decyl Cocoate)22.00dermosoft ®< GMCY MB (Glyceryl Caprylate)0.60dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus Seed Oil)0.20BCI 77891; Silica (Unipure White LC981 EM, Sensient)15.50CI 77492; Silica (Unipure Yellow LC182 EM, Sensient)1.90CI 77491(Unipure Red LC 381 EM, Sensient)0.60Cdermosoft ®< Pentiol eco (Pentylene Glycol)0.20DSpherilex ®< 10 PC (Hydrated Silica)1.75TEGO ®< Feel C 10 (Cellulose) 2.00 Pressed Powder

[0128] PhaseRaw materialw / w % ATEGO ®< Feel C 10 (Cellulose)20.00Tapioca Starch23.40Mica, Silica (Ronaflair M-Sphere, Merck KGaA)20.50Magnesium Stearate5.00CI 77891 (Hombitan AFDC 101, Venator)6.00CI 77891; CI 77491; CI 77492; CI 77499 (Cosnacolor Brown 147814, Cosnaderm)7.00BCI 77891; Mica; Tin Oxide (Ronaflair Balance Green, Merck KGaA)12.00CI 77891; Mica; Tin Oxide (Ronaflair Balance Gold, Merck KGaA)3.00CPhenethylalcohol nat. (Phenethyl Alcohol)1.00DTEGO ®< Turmerone (Curcuma Longa Root Extract) 0.10Example ##001# 2.00 After Shave Lotion

[0129] PhaseRaw materialw / w %w / w %AAbil ®< Care 85 (Bis-PEG / PPG-16 / 16 PEG / PPG-16 / 16 Dimethicone; Caprylic / Capric Triglyceride)1.50Abil ®< Care XL 80 (Bis-PEG / PPG-20 / 5 PEG / PPG-20 / 5 Dimethicone (and) Methoxy PEG / PPG-25 / 4 Dimethicone (and) Caprylic / Capric Triglyceride)1.50Tegosoft ®< CT (Caprylic / Capric Triglyceride)3.003.00Example ##001# 3.503.50Tocopheryl Acetate0.500.50Menthyl Lactate (Frescolat ML)0.500.50BTego ®< SMO 80 V (Polysorbate 80)0.500.50Waterto 100to 100Glycerin2.002.00Alcohol15.0015.00CTego ®< Carbomer 141 (Carbomer)0.200.20Xanthan Gum0.100.10Mineral Oil (30 mPas)1.601.60DSodium hydroxide (10% in water)q.s.q.s.ZPreservative, Perfumeq.s.q.s. W / O Emulsion

[0130] PhaseRaw materialw / w %w / w %AIsolan ®< GPS (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate)3.00Polyglyceryl-3 Diisostearate3.50Example ##001# 6.406.40Tegosoft ®< DEC (Diethylhexyl Carbonate)6.406.40Dicaprylyl Carbonate, Stearalkonium Hectorite, Propylene Carbonate (Cosmedia ®< Gel CC, Cognis)3.003.00BWaterto 100to 100Glycerin2.002.00Magnesium Sulfate Heptahydrate1.501.50CPhenoxyethanol, Ethylhexylglycerin (Euxyl ®< PE 9010, Schülke & Mayr)0.700.70 Anti-Ageing Moisturizing Cream

[0131] PhaseRaw materialw / w %ATego ®< Care 450 (Polyglyceryl-3 Methylglucose Distearate)3.00Tegin ®< M Pellets (Glyceryl Stearate)2.00Tego ®< Alkanol 18 (Stearyl Alcohol)1.00Tegosoft ®< MM (Myristyl Myristate)1.00Tegosoft ®< DO (Decyl Oleate)8.00Example ##001# 11.50Phytosphingosine SLC (Salicyloyl Phytosphingosine)0.10BGlycerin3.00Waterto 100CTego ®< Carbomer 134 (Carbomer)0.20Tegosoft ®< P (Isopropyl Palmitate)0.80DSodium hydroxide (10% in water)q.s.ZPreservative, Perfumeq.s. Transparent Sunscreen

[0132] PhaseRaw materialw / w %w / w %ATego ®< SP 13 Sun Up (Poly C10-30 Alkyl Acrylate)2.502.50dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.500.50Example ##001# 20.0015.00dermofeel ®< sensolv15.0015.00Tegosoft ®< CT (Caprylic / Capric Triglyceride)to20.00Butyl Methoxydibenzoylmethane3.003.00Ethylhexyl Salicylate5.005.00Octocrylene10.0010.00Homosalate10.0010.00AlcoholtoZPreservative, Perfumeq.sq.s Light O / W Sunscreen Lotion

[0133] PhaseRaw materialw / w %w / w %AAxol ®< C 62 Pellets (Glyceryl Stearate Citrate)2.50Potassium Cetyl Phosphate1.50Tego ®< Alkanol 1618 (Cetearyl Alcohol)1.001.00Example ##001# 6.006.00Isoadipate (Diisopropyl Adipate)3.003.00Butyloctyl Salicylate (HallBrite BHB, The HallStar Company)2.002.00Tocopheryl Acetate0.200.20Dimethicone (5 mPas)1.001.00Butyl Methoxydibenzoylmethane1.501.50Diethylamino Hydroxybenzoyl Hexyl Benzoate (Uvinul A Plus, BASF)4.004.00Ethylhexyl Triazone2.002.00Ethylhexyl Salicylate5.005.00Octocrylene8.008.00Ethylhexyl Methoxycrylene1.501.50BTitanium Dioxide; Trimethoxycaprylylsilane1.001.00CGlycerin3.203.20EDTA0.020.02Waterto 100to 100DAcrylates / C10-30 Alkyl Acrylate Crosspolymer0.100.10Example ##001# 0.900.90ESodium Hydroxide (10% in water)q.sq.sZPreservative, Perfumeq.sq.s. Sunscreen spray SPF 30

[0134] PhaseRaw materialw / w %ATego ®< Care PBS 6 MB (Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate)3.00C12-15 Alkyl Benzoate3.00Example ##001# 3.00Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (Tinosorb S, BASF)3.00Butyl Methoxydibenzoylmethane2.00Homosalate4.00Ethylhexyl Salicylate4.00Octocrylene4.00Tego ®< Feel C 10 (Cellulose)1.00BWaterto 100Gellan Gum (Kelcogel CG-HA, CP Kelco)0.03EDTA0.05Glycerin3.00Acrylates / C10-30 Alkyl Acrylate Crosspolymer0.20CPhenylbenzimidazole Sulfonic Acid2.00Tromethamine0.88Water7.12ETromethamine (Trisaminomethane, 30% in water)q.s.Fdermofeel ®< OMP (Methylpropanediol, Caprylyl Glycol, Phenylpropanol)3.00 Cationic Hand Cream

[0135] PhaseRaw materialw / w %AVarisoft ®< TA 100 (Distearyldimonium Chloride)3.50Tegin ®< M Pellets (Glyceryl Stearate)1.50Tego ®< Alkanol 18 (Stearyl Alcohol)1.00Example ##001# 13.00Tegosoft ®< DEC (Diethylhexyl Carbonate)8.00Tegosoft ®< CR (Cetyl Ricinoleate)1.00Triisostearin1.00BB Tego ®< Cosmo C 100 (Creatine)0.50Glycerin3.00Waterto 100ZPreservative, Perfumeq.s. PEG-Free AP / Deo roll-on

[0136] PhaseRaw materialw / w %w / w %w / w %w / w %ATego ®< Care APD 18 (Polyglyceryl-6 Stearate; Polyglyceryl-6 Behenate; C18-22 Hydroxyalkyl Hydroxypropyl Guar)5.005.003.50Steareth-23.20Steareth-200.80Cetearyl Alcohol1.50Example ##001# 5.005.005.005.00BWaterto 100to 100to 100to 100Glycerin3.003.003.003.00Potassium Alum5.00Aluminum Chlorohydrate 50% aq.20.0020.0020.00CPreservative, Perfumeq.s.q.s.q.s.q.s. Oil Release Lotion

[0137] PhaseRaw materialw / w %ATego ®< Care PBS 6 (Polyglyceryl-6 Stearate, Polyglyceryl-6 Behenate)3.00Tegosoft ®< DEC (Diethylhexyl Carbonate)10.00Example ##001# 26.00Tegosoft ®< OER (Oleyl Erucate)10.00Tegosoft ®< CT (Caprylic / Capric Triglyceride)15.00Tegosoft ®< AC (Isoamyl Cocoate)10.00Tego ®< Feel C 10 (Cellulose)1.00BWaterto 100Glycerin3.00CPhenoxyethanol, Ethylhexylglycerin (Euxyl PE 9010, Schülke & Mayr GmbH)0.70DCitric Acid (10% in water)q.s. W / O Sunscreen Lotion, Water-Resistant

[0138] PhaseRaw materialw / w %AIsolan ®< 17 MB (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate; Caprylic / Capric Triglyceride; Polyglyceryl-3 Oleate; Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate)4.00Paraffin; Cera Microcristallina (Paracera W 80, Paramelt)0.25Hydrogenated Castor Oil0.25Tegosoft ®< XC MB (Phenoxyethyl Caprylate)7.00Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (Tinosorb S, BASF)7.00Homosalate10.00Diethylamino Hydroxybenzoyl Hexyl Benzoate6.00Example ##001# 1.00 dermofeel ®< Toco 70 non GMO (Tocopherol, Helianthus Annuus (Sunflower) Seed Oil)0.50dermosoft ®< GMC MB (Glyceryl Caprate)0.50BWaterto 100Glycerin3.00Zinc Sulfate Heptahydrate1.00 W / O Make-Up Foundation

[0139] PhaseRaw materialw / w %w / w %w / w %w / w %w / w %w / w %AIsolan ®< 17 (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (and) Caprylic / Capric Triglyceride (and) Polyglyceryl-3 Oleate (and) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate)4.003.002.003.002.00Isolan ®< GPS (Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate)1.00Dehymuls PGPH (Polyglyceryl-2 Dipolyhydroxystearate)1.50Cithrol PG3PR (Polyglyceryl-3 Polyricinoleate)2.00Abil ®< EM 90 (Cetyl PEG / PPG-10 / 1 Dimethicone)1.503.00Dermofeel ®< sensolv (Isoamyl Laurate)7.006.005.007.002.506.00Decyl Cocoate4.004.004.003.00Isopropyl Myristate6.006.004.50Caprylic / Capric Triglyceride4.003.004.00Diethylhexyl Carbonate4.005.00Dimethicone15.00Example ##001# 2.005.005.002.006.004.50CI 77891 (and) Hydrogenated Lecithin5.005.005.005.005.00CI 77492 (and) Hydrogenated Lecithin0.600.600.600.600.60CI 77491 (and) Hydrogenated Lecithin0.350.350.350.350.35CI 77499 (and) Hydrogenated Lecithin0.100.100.100.100.10Disteardimonium Hectorite, Dimethicone, Propylene Carbonate2.002.002.002.002.00BWatertoto 100 to 100to 100to 100Sodium chloride1.001.001.50Magnesium Sulfate Heptahydrate1.502.00Glycerin3.003.003.005.005.00CPhenoxyethanol, Caprylyl Glycol1.001.001.001.001.00 Make-Up

[0140] PhaseRaw materialw / w %Adermofeel ®< viscolid MB (Hydrogenated Vegetable Oil)3.50Tegosoft ®< CR MB (Cetyl Ricinoleate)2.50Copernicia Cerifera (Carnauba) Wax1.00Example ##001# 35.00Persea Gratissima (Avocado) OiltoPrunus Amygdalus Dulcis (Sweet Almond) Oil3.50Argania Spinosa Kernel Oil0.50dermofeel ®< Toco 70 non GMO (Tocopherol; Helianthus Annuus (Sunflower) Seed Oil)0.50Tego ®< Feel C 10 (Cellulose)22.90Unipure White LC 981 HLC (CI 77891; Hydrogenated Lecithin, Sensient)15.00Unipure Yellow LC 182 HLC (CI 77492; Hydrogenated Lecithin, Sensient)1.20Unipure Red LC 381 HLC (CI 77491; Hydrogenated Lecithin, Sensient)0.70Unipure Black LC 989 HLC (CI 77499; Hydrogenated Lecithin, Sensient)0.20Titanium Dioxide; Silica; Mica; Alumina (RonaFlair Softshade, Merck)0.50Titanium Dioxide; Mica; Tin Oxide (RonaFlair Balance Blue, Merck)0.20Perfumeq.s. Formulation for Wet Wipes

[0141] Raw materialw / w %Pentylene Glycol2.0Glycerin1.0Tego ®< Solve 61 (Polyglyceryl-6 Caprylate; Polyglyceryl-3 Cocoate; Polyglyceryl-4 Caprate; Polyglyceryl-6 Ricinoleate)2.0Example ##001# 0.5Allantoin0.2Maltodextrin0.5Chamomilla Extract0.1Preservativeq.s.Perfumeq.s.Waterto 100.0Citric Acid, 30%to pH 5.5 Natural Baby Oil

[0142] Raw materialw / w %Example ##001# 35.00Squalane (C13-15 Alkane)10.0Helianthus Annuus (Sunflower) Seed Oil4.00Cocos Nucifera (Coconut) Oil10.00Limnanthes Alba (Meadowfoam) Seed Oil15.00Tegosoft ®< OER MB (Oleyl Erucate)10.00dermofeel ®< sensolv MB (Isoamyl Laurate)15.00dermofeel ®< Toco 70 non GMO1.00 Micellar Cleansing Water

[0143] Raw materialw / w %Waterto 100.0Tegosoft ®< PC 41 (Polyglyceryl-4 Caprate)5.5Preservativeq.s.Example ##001# 0.3Glycerin1.0Disodium EDTA0.2Citric Acid, 30%to pH 5.5 Micellar Water

[0144] Raw materialw / w %Rewoteric ®< AM C (Sodium Cocoamphopropionate)3.0Example ##001# 0.6Tegosoft ®< GMC 6 (PEG-6 Caprylic / Capric Glycerides)5.0Waterto 100.0Glycerin8.0Citric Acidto pH 5.5Preservativeq.s. Clear Conditioning Shampoo

[0145] Raw materialw / w %Example ##001# 0.1Texapon ®< NSO, BASF, 28% strength (INCI: Sodium Laureth Sulfate)32.00Rewoderm ®< LI S 80, Evonik Nutrition & Care GmbH (INCI: (PEG-200 Hydrogenated Glyceryl Palmate; PEG-7 Glyceryl Cocoate)2.00Perfume0.25Waterto 100.00Tego ®< Cosmo C 100, Evonik Nutrition & Care GmbH, (INCI: Creatine)1.50Jaguar C-162, Solvay, (INCI: Hydroxypropyl Guar Hydroxypropyltrimonium Chloride)0.20Tego ®< Betain F 50, Evonik Nutrition & Care GmbH, 38% strength (INCI: Cocamidopropyl Betaine)8.00NaCl2.50Citric acid, 30% strengthq.s. (pH 5.0)Preservativeq.s. Pearlescent Shampoo

[0146] Raw materialw / w %Texapon ®< NSO, BASF, 28% strength (INCI: Sodium Laureth Sulfate)32.00Example ##001# 0.20Perfume0.15Waterto 100.00Tego ®< Betain F 50, Evonik Nutrition & Care GmbH, 38% strength (INCI: Cocamidopropyl Betaine)8.00Tego ®< Pearl N 300, Evonik Nutrition & Care GmbH, (INCI: Glycol Distearate; Laureth-4; Cocamidopropyl Betaine)2.00Antil ®< 171 Evonik Nutrition & Care GmbH, (INCI: PEG-18 Glyceryl Oleate / Cocoate)2.50NaCl0.90Citric acid, 30% strengthq.s. (pH 5.5)Preservativeq.s. Matt conditioning shampoo

[0147] Raw materialw / w %Texapon ®< NSO, BASF, 28% strength (INCI:32.00Antil ®< 200, Evonik Nutrition & Care GmbH, (INCI: PEG-200 Hydrogenated Glyceryl Palmate; PEG-7 Glyceryl Cocoate)2.00Perfume0.25Waterto 100.00Polymer JR 400, Amerchol, (INCI: Polyquaternium-10)0.40Tego ®< Betain F 50, Evonik Nutrition & Care GmbH, 38% strength (INCI: Cocamidopropyl Betaine)8.00Example ##001# 0.50Tego ®< Pearl N 300, Evonik Nutrition & Care GmbH, (INCI: Glycol Distearate; Laureth-4; Cocamidopropyl Betaine)2.00NaCl0.30Citric acid, 30% strengthq.s. (pH 5.5)Preservativeq.s. Anti-Dandruff Shampoo

[0148] Raw materialw / w %Texapon ®< LS 35, BASF, 30% strength (INCI: Sodium Lauryl Sulfate)24.00Tagat ®< CH 40, Evonik Nutrition & Care GmbH, (INCI: PEG-40 Hydrogenated Castor Oil)2.00Tegosoft ®< GC, Evonik Nutrition & Care GmbH, (INCI: PEG-7 Glyceryl Cocoate)1.00Example ##001# 0.15Perfume0.20Waterto 100.00Polymer JR 400, Amerchol, (INCI: Polyquaternium-10)0.20Tego ®< Betain F 50, Evonik Nutrition & Care GmbH, 38% strength (INCI: Cocamidopropyl Betaine)16.00Hostapon SG, Clariant, (INCI : Sodium Cocoyl Glycinate)5.00Microcare ZP, Thor, (INCI: Zinc Pyrithione)0.200Octopirox, Clariant, (INCI: Octopirox)0.10Abil ®< Quat 3272, Evonik Nutrition & Care GmbH, (INCI: Quaternium-80)0.80Rewomid ®< D 212, Evonik Nutrition & Care GmbH, (INCI: Cocamide MEA)0.80Antil ®< 500, Evonik Nutrition & Care GmbH, (INCI: PEG-200 Glyceryl Stearate)0.80Glycerin1.50NaCl0.90Citric acid, 30% strengthq.s. (pH 5.5)Preservativeq.s. Shampoo, PEG-Free

[0149] Raw materialw / w %Texapon ®< LS 35, BASF, 30% (INCI: Sodium Lauryl Sulfate)28.00Waterto 100.00Ucare Polymer JR-400, Dow Chemicals, (INCI: Polyquaternium-10)0.10Jaguar C-162, Solvay, (INCI: Hydroxypropyl Guar Hydroxypropyltrimonium Chloride)0.10Antil ®< CM 90, Evonik Nutrition & Care GmbH, (INCI: Cocamide MEA)0.50Antil ®< SPA 80, Evonik Nutrition & Care GmbH, (INCI: Isostearamide MIPA; Glyceryl Laurate)1.00Xanthan Gum0.50Example ##001# 0.10Dehyton AB 30, BASF, 31%, (INCI: Coco-Betaine)8.00Prifrac 2920, Croda, (INCI: Lauric Acid)0.50Tegosoft ®< PC 41, Evonik Nutrition & Care GmbH, (INCI: Polyglyceryl-4 Caprate)1.00Glycerin1.00Uvinul MS 40, BASF, (INCI: Benzophenone-4)0.10Versene 100, The Dow Chemical Company, (INCI: Tetrasodium EDTA)0.10Sodium Chloride1.00Perfume, Preservativeq.s.Citric acid, 30% strengthq.s. (pH 5.0) Shampoo, Sulfate-Free

[0150] Raw materialw / w %Bioterge AS-40 AOS, Stepan, (INCI: Sodium C14-16 Olefin Sulfonate)30.00Waterto 100.00Jaguar C-162, Solvay, (INCI: Hydroxypropyl Guar Hydroxypropyltrimonium Chloride)0.15Antil ®< 500 Pellets, Evonik Nutrition & Care GmbH, (INCI: PEG-200 Glyceryl Stearate)0.20Antil ®< SPA 80, Evonik Nutrition & Care GmbH, (INCI: Isostearamide MIPA; Glyceryl Laurate)0.50Example ##001# 0.10Dehyton AB 30, BASF, 31%, (INCI: Coco-Betaine)8.00Tagat ®< CH 40, Evonik Nutrition & Care GmbH, (INCI: PEG-40 Hydrogenated Castor Oil)1.00Glycerin1.00Uvinul MS 40, BASF, (INCI: Benzophenone-4)0.10Sodium Chloride1.50Perfume, Preservativeq.s.Citric acid, 30% strengthq.s. (pH 5.5) Shampoo, Sulfate-Free

[0151] Raw materialw / w %Tego ®< Betain F 50, Evonik Nutrition & Care GmbH, 38% strength, (INCI: Cocamidopropyl Betaine)22.00Waterto 100.00Jaguar C-162, Solvay, (INCI: Hydroxypropyl Guar Hydroxypropyltrimonium Chloride)0.10Antil ®< 500 Pellets, Evonik Nutrition & Care GmbH, (INCI: PEG-200 Glyceryl Stearate)0.30Rewopal ®< PEG 6000 DS A, Evonik Nutrition & Care GmbH, (INCI: PEG-150 Distearate)0.50Example ##001# 0.10Hostapon SG, Clariant, (INCI: Sodium Cocoyl Glycinate)10.00Tego ®< Solve 61, Evonik Nutrition & Care GmbH,1.00(INCI: Polyglyceryl-6 Caprylate; Polyglyceryl-3 Cocoate; Polyglyceryl-4 Caprate; Polyglyceryl-6 Ricinoleate)Glycerin0.50Sodium Chloride1.00Perfume, Preservativeq.s.Citric acid, 30% strengthq.s. (pH 4.8) Rinse-Off Conditioner

[0152] Raw materialw / w %Waterto 100.00Varisoft ®< EQ 65, Evonik Nutrition & Care GmbH, (INCI: Distearoylethyl Dimonium Chloride; Cetearyl Alcohol)2.00Varisoft ®< BT 85, Evonik Nutrition & Care GmbH, (INCI: Behentrimonium Chloride)1.00Example ##001# 0.20Tego ®< Alkanol 1618, Evonik Nutrition & Care GmbH, (INCI: Cetearyl Alcohol)5.00Citric acid, 30% strengthq.s. (pH 4.0)Preservative, Perfumeq.s. Rinse-Off Conditioner

[0153] Raw materialw / w %Waterto 100.00Tegin ®< M Pellets, Evonik Nutrition & Care GmbH, (INCI: Glyceryl Stearate)1.00Tego ®< Care PSC 3, Evonik Nutrition & Care GmbH, (INCI: Polyglyceryl-3 Dicitrate / Stearate)0.50Jaguar C-162, Solvay, (INCI: Hydroxypropyl Guar Hydroxypropyltrimonium Chloride)0.10Example ##001# 1.00Tego ®< Alkanol 1618, Evonik Nutrition & Care GmbH, (INCI: Cetearyl Alcohol)6.00Citric acid, 30% strengthq.s. (pH 4.5)Preservative, Perfumeq.s.

Claims

1. Mixture composition comprising a first alkyl carboxylate group of the general formula (la) and a second alkyl carboxylate group of the general formula (Ib) with R1a and R1b chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon acyl radicals exhibiting from 10 to 30, preferably from 10 to 22, particularly preferably from 10 to 18, carbon atoms, R2a and R2b each chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon radicals exhibiting from 12 to 22, preferably from 12 to 18, particularly preferably from 12 to 14, carbon atoms, with the proviso that R2a is different from R2b, and that the alkyl carboxylates of the first group and of the second group in total are present in an amount of at least 55% by weight, preferably at least 70% by weight, particularly preferably at least 80% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition, characterized in that the ratio by weight of all alkyl carboxylates of the first group to all alkyl carboxylates of the second group is from 10.0:1.0 to 1.0:1.0, preferably from 4.0:1.0 to 1.5:1.0, particularly preferably from 3.5:1.0 to 2.0:1.0.

2. Mixture composition according to Claim 1, characterized in that the amount of R1a, R1b, R2a and R2b radicals in total, which exhibit an uneven number of carbon atoms, is less than or equal to 40% by weight, preferably less than 20% by weight, more preferably still less than 10% by weight, particularly preferably less than 3.0% by weight, the percentages by weight referring to all R1a, R1b, R2a and R2b radicals present in the mixture composition.

3. Mixture composition according to Claim 1 or 2, characterized in that R2a is a lauryl radical and R2b is a myristyl radical.

4. Mixture composition according to at least one of the preceding claims, characterized in that R1a and R1b are chosen from saturated or unsaturated, linear, hydrocarbon acyl radicals exhibiting 18 carbon atoms, preferably unsaturated, particularly preferably mono- and diunsaturated.

5. Mixture composition according to at least one of Claims 3 and 4, characterized in that the alkyl carboxylates of the first group and of the second group are present in total in an amount of 70% by weight to 99% by weight, preferably 85% by weight to 95% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

6. Mixture composition according to at least one of Claims 3 to 5, characterized in that the alkyl carboxylates of the second group are present in an amount of 15% by weight to 35% by weight, preferably 20% by weight to 30% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

7. Mixture composition according to at least one of Claims 3 to 6, characterized in that it contains lauryl palmitate and / or myristyl myristate in total in an amount of 0.5% by weight to 7.0% by weight, in particular of 1.0% by weight to 5.0% by weight, the percentages by weight referring to all alkyl carboxylates present in the mixture composition.

8. Process comprising the process stages A) supplying a first alcohol and a second alcohol, different from the first alcohol, chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, hydrocarbon alcohols exhibiting from 12 to 22, preferably from 12 to 18, particularly preferably from 12 to 14, carbon atoms, B) supplying at least one acid chosen from saturated or unsaturated, linear or branched, optionally hydroxy-substituted, carboxylic acids exhibiting from 10 to 30, preferably from 10 to 22, particularly preferably from 10 to 18, carbon atoms, C) esterifying the first and second alcohols with the acid, with an ester composition being obtained, and optionally D) purifying the ester composition, characterized in that the ratio by weight of the amount of the first alcohol to the amount of the second alcohol is from 85.0:15.0 to 1.0:1.0, preferably from 80.0:20.0 to 65.0:35.0, characterized in that the sum of the amount of the first alcohol and of the amount of the second alcohol comes to at least 55% by weight, preferably at least 70% by weight, particularly preferably at least 80% by weight, with reference to all alcohols used in the process.

9. Process according to Claim 8, characterized in that the first alcohol is chosen from lauryl alcohol and the second alcohol is chosen from myristyl alcohol.

10. Process according to at least one of Claims 8 or 9, characterized in that the acid is chosen from oleic acid and linoleic acid.

11. Process according to at least one of Claims 8 to 10, characterized in that process stage C) is carried out by enzyme catalysis.

12. Ester composition obtainable by a process according to at least one of Claims 8 to 11.

13. Use of a mixture composition according to at least one of Claims 1 to 7 and / or of an ester composition according to Claim 12 for the preparation of a cosmetic formulation, in particular of a cosmetic sunscreen formulation.

14. Use of a mixture composition according to at least one of Claims 1 to 7 and / or of an ester composition according to Claim 12 for the dispersing of solid pigments and / or for the dissolution of organic UV screening agents.